Cambrex to Present at Upcoming Investor Conferences in September

EAST RUTHERFORD, N.J., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that company management will present at the following investor conferences in September:

2017 Wells Fargo Healthcare ConferenceDate:  Wednesday, September 6, 2017Time:  4:10 p.m. EDTLocation:  Boston, MA

Baird’s 2017 Global Healthcare ConferenceDate:  Thursday, September 7, 2017Time:  10:15 a.m. EDTLocation:  New York, NY

The live audio webcasts and slide presentations can be accessed from the Cambrex website at www.cambrex.com in the Investors section under “Webcasts & Presentations”, and replays will be available for 90 days after the live events conclude. 

About Cambrex Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances.  For more information, please visit www.cambrex.com.

Contact:
Stephanie LaFiura
Investor Relations Associate
Tel: 201.804.3037
Email:  [email protected]

You May Also Be Interested In

• LBMC Names Charlie Apigian, Ph.D., to Lead AI and Data Transformation Practice
• Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
• ARKBRIDGE’s David Mali Highlights AI-Driven Risk Management at the Finance Magnates London Summit